Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials
Over the past five years, there has been a considerable increase in clinical research on cannabinoid use for a range of pain syndromes. Cannabinoid products are becoming available for research and clinical use, and pharmaceutical industry interest in the potential for cannabinoids in therapeutics is...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2005/847562 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832548442379911168 |
---|---|
author | Mark Ware Pierre Beaulieu |
author_facet | Mark Ware Pierre Beaulieu |
author_sort | Mark Ware |
collection | DOAJ |
description | Over the past five years, there has been a considerable increase in clinical research on cannabinoid use for a range of pain syndromes. Cannabinoid products are becoming available for research and clinical use, and pharmaceutical industry interest in the potential for cannabinoids in therapeutics is also gaining momentum. The present article summarizes recent clinical trial data in the field of pain management and suggests that the potential for cannabinoid therapy for chronic pain states is encouraging. Clinicians working in pain management should be aware of the options becoming available from the cannabinoid class of medications. |
format | Article |
id | doaj-art-f7c0a2405b864d37b5a953fae0726007 |
institution | Kabale University |
issn | 1203-6765 |
language | English |
publishDate | 2005-01-01 |
publisher | Wiley |
record_format | Article |
series | Pain Research and Management |
spelling | doaj-art-f7c0a2405b864d37b5a953fae07260072025-02-03T06:14:08ZengWileyPain Research and Management1203-67652005-01-0110Suppl A27A30A10.1155/2005/847562Cannabinoids for the Treatment of Pain: An Update on Recent Clinical TrialsMark Ware0Pierre Beaulieu1McGill University, Montreal, Quebec, CanadaUniversité de Montréal, Montreal, Quebec, CanadaOver the past five years, there has been a considerable increase in clinical research on cannabinoid use for a range of pain syndromes. Cannabinoid products are becoming available for research and clinical use, and pharmaceutical industry interest in the potential for cannabinoids in therapeutics is also gaining momentum. The present article summarizes recent clinical trial data in the field of pain management and suggests that the potential for cannabinoid therapy for chronic pain states is encouraging. Clinicians working in pain management should be aware of the options becoming available from the cannabinoid class of medications.http://dx.doi.org/10.1155/2005/847562 |
spellingShingle | Mark Ware Pierre Beaulieu Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials Pain Research and Management |
title | Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials |
title_full | Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials |
title_fullStr | Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials |
title_full_unstemmed | Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials |
title_short | Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials |
title_sort | cannabinoids for the treatment of pain an update on recent clinical trials |
url | http://dx.doi.org/10.1155/2005/847562 |
work_keys_str_mv | AT markware cannabinoidsforthetreatmentofpainanupdateonrecentclinicaltrials AT pierrebeaulieu cannabinoidsforthetreatmentofpainanupdateonrecentclinicaltrials |